BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19479063)

  • 1. Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.
    Rotunno M; Yu K; Lubin JH; Consonni D; Pesatori AC; Goldstein AM; Goldin LR; Wacholder S; Welch R; Burdette L; Chanock SJ; Bertazzi PA; Tucker MA; Caporaso NE; Chatterjee N; Bergen AW; Landi MT
    PLoS One; 2009 May; 4(5):e5652. PubMed ID: 19479063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non smokers in lung cancer.
    Ihsan R; Chauhan PS; Mishra AK; Yadav DS; Kaushal M; Sharma JD; Zomawia E; Verma Y; Kapur S; Saxena S
    PLoS One; 2011; 6(12):e29431. PubMed ID: 22206016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-and-neck squamous cell carcinoma risk in smokers: no association detected between phenotype and AHR, CYP1A1, CYP1A2, or CYP1B1 genotype.
    Jorge-Nebert LF; Zhang G; Wilson KM; Jiang Z; Butler R; Gluckman JL; Pinney SM; Nebert DW
    Hum Genomics; 2016 Nov; 10(1):39. PubMed ID: 27894333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women.
    Yoon KA; Kim JH; Gil HJ; Hwang H; Hwangbo B; Lee JS
    Lung Cancer; 2008 Apr; 60(1):40-46. PubMed ID: 17980933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk.
    Pande M; Spitz MR; Wu X; Gorlov IP; Chen WV; Amos CI
    Carcinogenesis; 2011 Oct; 32(10):1493-9. PubMed ID: 21771723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China.
    Song N; Tan W; Xing D; Lin D
    Carcinogenesis; 2001 Jan; 22(1):11-6. PubMed ID: 11159735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic association of CYP1A1 polymorphisms with increased susceptibility to squamous cell lung cancer in north Indian smokers.
    Girdhar Y; Singh N; Behera D; Sharma S
    Int J Biol Markers; 2016 Dec; 31(4):e402-e412. PubMed ID: 27396354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case-only analysis.
    Pande M; Amos CI; Eng C; Frazier ML
    Mol Carcinog; 2010 Nov; 49(11):974-80. PubMed ID: 20886582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population.
    Islam MS; Ahmed MU; Sayeed MS; Maruf AA; Mostofa AG; Hussain SM; Kabir Y; Daly AK; Hasnat A
    Clin Chim Acta; 2013 Feb; 416():11-9. PubMed ID: 23178447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.
    Li Y; Sheu CC; Ye Y; de Andrade M; Wang L; Chang SC; Aubry MC; Aakre JA; Allen MS; Chen F; Cunningham JM; Deschamps C; Jiang R; Lin J; Marks RS; Pankratz VS; Su L; Li Y; Sun Z; Tang H; Vasmatzis G; Harris CC; Spitz MR; Jen J; Wang R; Zhang ZF; Christiani DC; Wu X; Yang P
    Lancet Oncol; 2010 Apr; 11(4):321-30. PubMed ID: 20304703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.
    Alexandrie AK; Nyberg F; Warholm M; Rannug A
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):908-14. PubMed ID: 15184245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
    Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
    Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional evaluation of novel single nucleotide polymorphisms and haplotypes in the promoter regions of CYP1B1 and CYP1A1 genes.
    Han W; Pentecost BT; Spivack SD
    Mol Carcinog; 2003 Jul; 37(3):158-69. PubMed ID: 12884367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.
    Choudhury JH; Singh SA; Kundu S; Choudhury B; Talukdar FR; Srivasta S; Laskar RS; Dhar B; Das R; Laskar S; Kumar M; Kapfo W; Mondal R; Ghosh SK
    Tumour Biol; 2015 Aug; 36(8):5773-83. PubMed ID: 25724184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels.
    Butkiewicz D; Cole KJ; Phillips DH; Harris CC; Chorazy M
    Eur J Cancer Prev; 1999 Aug; 8(4):315-23. PubMed ID: 10493307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive meta-analysis and a case-control study give insights into genetic susceptibility of lung cancer and subgroups.
    Sengupta D; Banerjee S; Mukhopadhyay P; Mitra R; Chaudhuri T; Sarkar A; Bhattacharjee G; Nath S; Roychoudhury S; Bhattacharjee S; Sengupta M
    Sci Rep; 2021 Jul; 11(1):14572. PubMed ID: 34272429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts.
    Mollerup S; Berge G; Baera R; Skaug V; Hewer A; Phillips DH; Stangeland L; Haugen A
    Int J Cancer; 2006 Aug; 119(4):741-4. PubMed ID: 16557573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China.
    Yin L; Pu Y; Liu TY; Tung YH; Chen KW; Lin P
    Lung Cancer; 2001; 33(2-3):133-41. PubMed ID: 11551408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.